The Anti-β2-Glycoprotein I Activity in Human Anti-Phospholipid Syndrome Sera Is Due to Monoreactive Low-Affinity Autoantibodies Directed to Epitopes Located on Native β2-Glycoprotein I and Preserved during Species' Evolution

Journal of Immunology

Volumn 157, Issue 12, 1996, Pages 5732-5738

  Tincani, Angela ^a   Spatola, Laura ^a   Prati, Enrica ^a   Allegri, Flavio ^a   Ferremi, Piero ^a   Cattaneo, Roberto ^b   Meroni, Pierluigi ^a   Balestrieri, Genesio ^a,c  

^a Clinical Immunology Unit   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Ospedale Civile   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; BETA2 GLYCOPROTEIN 1; GLYCOPROTEIN;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; EPITOPE MAPPING; FEMALE; HUMAN; IMMUNOLOGY; SPECIES DIFFERENCE;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; EPITOPE MAPPING; FEMALE; GLYCOPROTEINS; HUMANS; SPECIES SPECIFICITY;

EID: 0030589375     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. 2-glycoprotein I (apolipoprotein H). Proc. Natl. Acad. Sci. USA 87:4120.
2. Galli, M., P. Comfurius, H. C. Hemker, M. H. Debaets, P. J. C. van Breda-Vreisman, T. Barbui, R. F. A. Zwaal, and E. M. Bevers. 1990. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to plasma protein cofactor. Lancet 335:1544.
3. Matsuura, E., Y. Igarashi, M. Fujimoto, K. Ichikawa, and T. Koike. 1990. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune diseases. Lancet 336:177.
4. 2-glycoprotein I: a plasma inhibitor of contact activation of the intrinsic blood coagulation pathway. Blood 66:1085.
5. 2-glycoprotein I (apolipoprotein H) interaction with phospholipid vesicles. Int. J. Biochem. 16:511.
6. 2-glycoprotein I as antigen. J. Immunol. Methods 143:223.
7. 2-glycoprotein I: comparison with a standard anticardiolipin assay. Arthritis Rheum. 37:S298 (Abstr.).
8. 2-glycoprotein I: a marker of antiphospholipid syndrome? Lupus 4:122.
9. 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. Am. J. Med. 93:181.
10. 2-glycoprotein I in patients with primary antiphospholipid syndrome. J. Rheumatol. 22:1894.
11. 2-glycoprotein I than with antiphospholipid antibodies. J. Rheumatol. 22:1899.
12. Martinuzzo, M. E., R. R. Forastriero, and L. O. Carreras. 1995. Anti-beta 2 glycoprotein I antibodies: detection and association with thrombosis. Br. J. Haematol. 89:397.
13. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J. Exp. Med. 179:457.
14. 2-glycoprotein I is bound to a suitable surface. Thromb. Haemost. 73:29.
15. 2-GPI: epitope mapping studies. Lupus 4(Suppl. 2):149 (Abstr.).
16. 2-glycoprotein I in the absence of phospholipid. J. Immunol. 154:954.
17. 2 glycoproteine I. Ann. Biol. Clin. 52:381.
18. 2 glycoprotein I and placental anticoagulant protein I in placentae from patients with antiphospholipid syndrome. J. Rheumatol. 21: 1684.
19. 2-glycoprotein I in the rat: isolation from serum and demonstration in lipoprotein density fraction. J. Biochem. 11:265.
20. Hardy, R. R. 1986. Purification and characterization of monoclonal antibodies. In Handbook of Experimental Immunology, Vol. 1. D. M. Weir, ed. Blackwell Scientific Publications, Oxford, p. 13.1.
21. Bartlett, G. R. 1959. Phosphorus assay in column chromatography. J. Biol. Chem. 234:466.
22. Staub, H. L., E. N. Harris, M. Khamashta, G. Savidge, W. H. Chahade, and G. R. V. Hughes. 1989. Antibody to phosphalidylethanolamine in a patient with lupus anticoagulant and thrombosis. Ann. Rheum. Dis. 48:166.
23. Ter Borg, E. J., G. Horst, E. J. Hummel, P. C. Limburg, and C. G. M. Kallenberg. 1990. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. Arthritis Rheum. 33:634.
24. Harris, E. N., A. E. Gharavi, A. Tincani, J. K. H. Chan, H. Englert, P. Mantelli, F. Allegri, G. Balestrieri, and G. R. V. Hughes. 1985. Affinity purified anticardiolipin and anti-DNA antibodies. J. Clin. Lab. Immunol. 17:155.
25. Friguet, B., A. F. Chaffotte, L. Djavadi-Ohaniance, and M. E. Goldberg. 1985. Measurement of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods 77:305.
26. Rodbard, D., and S. W. McLean. 1977. Automated computer analysis for enzyme multiplied immunological techniques. Clin. Chem. 23:112.
27. 2-glycoprotein I in the absence of phospholipid. Br. J. Haematol. 82:571.
28. 2-GPI in alternation of anticardiolipin binding. Int. Immunol. 3:1217.
29. 2 glycoprotein I: the presence of five sushi domains. Biochemistry 30:11687.
30. 2-glycoprotein I. Br. J. Haematol. 81:568.
31. Romans, D. G., C. A. Tilley, and K. J. Dorrington. 1980. Monogamous bivalency of IgG antibodies. I. Deficiency of branched ABHI-active oligosaccharide chains on red cells of infants causes the weak antiglobulin reactions in hemolytic disease of the newborn due to ABO incompatibility. J. Immunol. 124:2807.
32. 2 glycoprotein I (apolipoprotein H) as cofactor. J. Rheumatol. 48:484.
33. 2-GPI). Clin. Exp. Immunol. 102:373.
34. 2-glycoprotien I antibodies derived from patients with the antiphospholipid syndrome. J. Immunol. 155:1629.
35. Peterfy, F., P. Kuusela, and O. Makela. 1983. Affinity requirements for antibody assay mapped by monoclonal antibodies. J. Immunol. 130: 1809.
36. Steward, M. W., and M. L. Lew. 1985. The importance of antibody affinity in the performance of immunoassays for antibody. J. Immunol. Methods 78:173.
37. 2 glycoprotein I mediates the antibody binding to endothelial membranes and induces the expression of adhesion molecules. Clin. Exp. Rheumatol. 13:179.